21.218 articles found

Better therapeutic efficiency of omnidirectional than directional subthalamic deep brain stimulation in Parkinson’s disease

Scherer M, Milosevic L, Cebi I, Bookjans P, Brunett B, Guggenberger R, Weiss D, Gharabaghi A.

· 2023-11-01

DOI: 10.1101/2023.11.01.23297794

SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of vidarabine against rotenone-induced neural cell injury

Li L, Zhang Y, Chen Z, Yao R, Xu Z, Xu C, He F, Pei H, Hao C.

Heliyon · 2023-11-01

The Effectiveness of Classical Ballet as a Therapeutic Intervention: A Narrative Review.

Haussler AM, Earhart GM.

Altern Ther Health Med · 2023-11-01

PMID: 36150009

Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases.

Xue W, Zhang J, Li Y.

Neural Regen Res · 2023-11-01

DOI: 10.4103/1673-5374.371346PMID: 37282455

Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo<sup>®</sup> ) in Parkinson's disease.

Reichmann H.

Eur J Neurol · 2023-11-01

DOI: 10.1111/ene.15992PMID: 37489705

Stalevo<sup>®</sup> : A pioneering treatment for OFF periods in Parkinsons disease.

Jenner P.

Eur J Neurol · 2023-11-01

DOI: 10.1111/ene.15994PMID: 37500177

Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance.

Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, Giglio A, George SS, Uribe-Herranz M, Costabile F, Pierini S, Pustylnikov S, Skoufos G, Barash Y, Hatzigeorgiou AG, Koumenis C, Maity A, Lotze MT, Facciabene A.

Cancer Res · 2023-11-01

DOI: 10.1158/0008-5472.can-22-2499PMID: 37578274

DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson's disease.

Tananta VL, Costa EV, Mary YS, Mary YS, S Al-Otaibi J, Costa RA.

J Mol Model · 2023-11-01

DOI: 10.1007/s00894-023-05756-5PMID: 37907772

Circuit-specific gene therapy is knocking on the door of Parkinson's disease.

Wang YQ, Yin M, Guo ZS.

Zool Res · 2023-11-01

DOI: 10.24272/j.issn.2095-8137.2023.353PMID: 37975512

Establishment of a Mathematical Model for Parkinson's Disease Based on Complex Neural Networks and Design of Deep Brain Electrical Stimulation Treatment Plans.

Sun H, Lv C, Sun X, Guo R.

Stud Health Technol Inform · 2023-11-01

DOI: 10.3233/shti230906PMID: 38007805

Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.

Godse S, Zhou L, Sakshi S, Singla B, Singh UP, Kumar S.

Exp Biol Med (Maywood) · 2023-11-01

DOI: 10.1177/15353702231211863PMID: 38058006

Serum BLMH and CKM as Potential Biomarkers for Predicting Therapeutic Effects of Deep Brain Stimulation in Parkinson's Disease: A Proteomics Study.

Gong Y, Qian S, Chen D, Ye M, Wu J, Wang YL.

J Integr Neurosci · 2023-11-01

DOI: 10.31083/j.jin2206163PMID: 38176938